RETATRUTIDE 10MG

Retatrutide (LY-3437943) – 10 MG

Retatrutide (LY-3437943) is a novel triple agonist of the GLP-1, GIP, and glucagon receptors. Designed to synergistically improve glycemic control and weight management, it represents a new class of incretin-based molecules under investigation for obesity, type 2 diabetes, and metabolic disorders.

Key Features:

• ✔️ Triple-agonist incretin analog for advanced metabolic studies
• ✔️ Lyophilized for stability and dosing accuracy
• ✔️ QC verified for sequence fidelity and batch purity

Product Details:

• Contents: 10 MG Retatrutide peptide
• Appearance: White to off-white lyophilized powder
• Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• M.W.: ~4731.3 g/mol
• CAS #: 2381089-83-2
• Storage: Store at −20 °C; protect from moisture and light
• Intended Use: For laboratory research use only

Note: Not for human or veterinary use. For in-vitro research only.